Supplemental material
Journal of Drug Assessment
Volume 8, 2019 - Issue 1
Open access
1,678
Views
0
CrossRef citations to date
0
Altmetric
Oncology
Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists
Pedro Sánchez-RoviraComplejo Hospitalario de Jaén, Jaén, Spain; Correspondence[email protected]
, Pilar ZamoraHospital Universitario La Paz, Madrid, Spain;
, Javier Salvador-BofillHospital Universitario Nuestra Señora de Valme, Sevilla, Spain;
, Serafín MoralesHospital Universitari Arnau de Vilanova, Lleida, Spain;
, Noelia Martínez-JáñezHospital Universitario Ramón y Cajal, Madrid, Spain;
, Eduardo Martínez-de-DueñasConsorcio Hospitalario i Provincial de Castellón, Castellón, Spain;
, Ana LluchHospital ClínicUniversitari de València, València, Spain;
, José Juan IllarramendiComplejo Hospitalario de Navarra, Pamplona, Spain;
, Patricia Gómez-PardoHospital Universitari Vall d’Hebron, Barcelona, Spain;
, Joaquín Gavilá GregoriFundación Instituto Valenciano de Oncología, Valencia, Spain;
, Andrés García-PalomoComplejo Asistencial de León, Léon, Spain;
, Jesús García-MataHospital Santa María Nai en Ourense, Orense, Spain;
, Yolanda FernándezHospital Universitario Central de Asturias, Oviedo, Spain;
, Sonia del BarcoInstitut Catalàd’Oncologia, Girona, Spain;
, Ana de JuanHospital Universitario Marqués de Valdecilla, Santander, Spain;
, Eva CiruelosHospital Universitario 12 de Octubre, Madrid, Spain;
, José Ignacio ChacónHospital Virgen de la Salud, Toledo, Spain;
, Lourdes CalvoComplejo Hospitalario Universitario de A CoruñaA Coruña, Spain;
, Agustí BarnadasHospital de la Santa Creu i Sant Pau, Barcelona, Spain;
& Joan AlbanellHospital del Mar, Barcelona, Spain
show all
Pages 62-69
|
Received 09 Oct 2018, Accepted 26 Mar 2019, Published online: 30 Apr 2019
Related Research Data
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Source:
New England Journal of Medicine (NEJM/MMS)
Defining the optimal sequence for the systemic treatment of metastatic breast cancer
Source:
Springer Nature
Endocrine therapy in post-menopausal women with metastatic breast cancer: From literature and guidelines to clinical practice
Source:
Elsevier BV
Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists
Source:
Taylor & Francis
1st International consensus guidelines for advanced breast cancer (ABC 1)
Source:
Elsevier BV
Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer
Source:
Elsevier BV
Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study
Source:
Elsevier BV
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
Source:
Elsevier BV
A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer
Source:
SAGE Publications
SEOM clinical guidelines in metastatic breast cancer 2015
Source:
Springer Nature
Metastatic Behavior of Breast Cancer Subtypes
Source:
American Society of Clinical Oncology (ASCO)
Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists
Source:
Informa UK Limited
Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal
Source:
Elsevier BV
Current and emerging therapies of HER2-positive metastatic breast cancer
Source:
Elsevier BV
Trastuzumab-DM1: Building a Chemotherapy-Free Road in the Treatment of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Source:
American Society of Clinical Oncology (ASCO)
Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
Source:
American Society of Clinical Oncology (ASCO)
Cancer incidence in Spain, 2015
Source:
Springer Nature
Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG)
Source:
Elsevier BV
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.